SPARC and ovarian carcinoma: In function assay, by lentivirus-mediated RNA interference, we decreased the expression of SPARC in highly invasive subclone S1 and HO8910PM to determine the effect of SPARC on ovarian cancer cell proliferation, apoptosis, invasion and metastasis.